Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Medicine Maker
  • Explore

    Explore

    • Latest
    • Features
    • Interviews
    • Business & Trends
    • Technology & Manufacturing
    • Product Profiles
    • White Papers

    Featured Topics

    • Biopharma
    • Small Molecules
    • Cell & Gene
    • Future of Pharma

    Issues

    • Latest Issue
    • Archive
    • Cell and Gene Therapy Supplement
  • Topics

    Topics

    • Drug Discovery
    • Development & Clinical
    • Formulation
    • Drug Delivery
    • Bioprocessing
    • Small Molecules
    • Cell and Gene
    • Facilities & Equipment
    • Outsourcing
    • Packaging
    • Supply Chain
    • Regulation & Standards
  • News & Blogs

    News & Blogs

    • Industry News
    • Research News
    • Blogs
  • Events
    • Live Events
    • Webinars
  • Community & Awards

    Community & Awards

    • Power List
    • Sitting Down With
    • Innovation Awards
    • Company of the Year Awards
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
    • eBooks
Subscribe
Subscribe
The Medicine Maker / Issues / 2019 / Articles / Oct / Solutions in… Automated Quality Reporting
Manufacture Digital Technologies

Solutions in… Automated Quality Reporting

Could an AI tool help stakeholders from the scientific community address the current state of reproducibility in scientific results?

By Maryam Mahdi 10/26/2019 0 min read

Share

Reproducibility is at the heart of scientific research – or at least it should be. Not only does it prove the rigor of research, it lays the foundations for the transparency and credibility of projects conducted. But there is growing concern about the number of studies with irreproducible results. Digital Science portfolio company, Ripeta, has developed an AI tool that scans manuscripts for the proper reporting of scientific method components to detect and predict the reproducibility of scientific research. Here, we speak to Leslie McIntosh, CEO of Ripeta, to find out how such tools can help advance scientific research.

Non-reproducible research questions the science. It is actually intriguing on one hand, as there may be something in the scientific process that has not been identified, such as variables that haven’t been identified or taken into account, that positively influence the science. However, far too many variables exist that could influence research outcomes. Ultimately, having reproducible research builds (or weakens) trust in the scientific work. Effective reproducibility lies at the heart of the scientific method.

Leslie McIntosh, CEO of Ripeta.

The scientific community is an ecosystem made up of stakeholders from varying backgrounds. Researchers, funders, institutions, and publishers must take some responsibility in improving the reporting of research. However, no single stakeholder is fully responsible for making a change. Improvement in research quality will come when multiple actors in this network decide to make changes – including aligning incentives for researcher promotion with conducting and reporting better quality research. 

Lastly, good research should be a commitment towards transparency even when accessibility of all pieces is not possible. As mentioned in our “Making Science Better” report (1), if we start from a simple construct of what good research is, then it starts with a well defined study objective or hypothesis.

There are a few exciting things in the works. One is to expand what we have automated to include other variables and to also provide contextual feedback to help authors make improvements with less work. For example, if they stated their software but don’t cite it, the tool can offer a suggested citation or point towards how to find the citation. In addition to analyzing one paper, we are currently summarizing the results across a grouping (for example, multiple articles from one journal, research topic, company) and creating reports. The aggregated data will eventually be displayed through a dashboard for easier viewing.

Newsletters

Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

References

  1. Digital Science, “Making Science Better: Reproducibility, Falsifiability and the Scientific Method,” (2019). Available at https://bit.ly/2LW58V5. Last accessed October 8, 2019. 

About the Author(s)

Maryam Mahdi

After finishing my degree, I envisioned a career in science communications. However, life took an unexpected turn and I ended up teaching abroad. Though the experience was amazing and I learned a great deal from it, I jumped at the opportunity to work for Texere. I'm excited to see where this new journey takes me!

More Articles by Maryam Mahdi

False

Advertisement

Recommended

False

Related Content

The Next Decade of Cell and Gene Therapies
Advanced Medicine Bioprocessing - Upstream & Downstream Trends & Forecasts Digital Technologies
The Next Decade of Cell and Gene Therapies

May 7, 2025

5 min read

Off-the-shelf allogeneic CAR-Ts, increased manufacturing productivity led by digital systems, and more; we ask experts about the future of advanced medicine.

Partnership Cuts Cost of CAR T Manufacturing
Advanced Medicine Technology and Equipment Digital Technologies
Partnership Cuts Cost of CAR T Manufacturing

March 13, 2025

4 min read

Manufacturing bottlenecks remain a key hurdle in CAR-T therapy. Can automation and digital integration change that? Trenchant and Autolomous explore the possibilities.

Forecasting Medicine Use and Controlling Supply Chains
Digital Technologies Standards & Regulation Supply Chain
Forecasting Medicine Use and Controlling Supply Chains

March 19, 2025

3 min read

The role of digital technologies in optimizing traceability in pharmaceutical supply chains.

AI, Big Data, and Digital Disruption
Digital Technologies Clinical Trials
AI, Big Data, and Digital Disruption

March 31, 2025

7 min read

An industry survey looks at changing attitudes and challenges in digital innovation for clinical research. Uptake is slow but steady.

The Medicine Maker
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.